Your session is about to expire
← Back to Search
Home Telemonitoring for Heart Attack
Study Summary
This trial is testing a new way to monitor heart health using a portable device and phone call follow-ups. They hope it will improve patient outcomes and reduce ER visits and hospital readmissions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a cardiac arrest not caused by a heart attack, with any brain injury.I have had a heart attack recently.I don't have a smartphone or home internet for constant ECG transmission.I can use a home ECG monitoring device.I am scheduled for a staged PCI after my current hospital stay.You don't have people at home who can help you.You have an ECG with certain irregularities, or you have a pacemaker or implantable cardioverter defibrillator that relies on pacing.
- Group 1: Control (standard treatment) Group
- Group 2: SmartHeart Device Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current enrollment of participants in this trial?
"Affirmative. Per the information found on clinicaltrials.gov, this study is currently in search of applicants and launched on October 14th 2020. The total number of patients needed amounts to 240 and will be recruited from a single medical centre."
Is it feasible for individuals to sign up now for this medical experiment?
"Confirmation of this can be found on clinicaltrials.gov, where the trial is documented to have been first posted in October 14th 2020 and edited most recently on February 17th 2022. It appears that recruitment for patients is still ongoing."
Share this study with friends
Copy Link
Messenger